The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 383.50
Bid: 388.00
Ask: 390.00
Change: -4.50 (-1.16%)
Spread: 2.00 (0.515%)
Open: 392.50
High: 393.00
Low: 383.50
Prev. Close: 388.00
BNC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New issue: PCCS

18 Apr 2017 07:42

RNS Number : 5546C
Banco Santander S.A.
18 April 2017
 

 

 

 

 

MATERIAL FACT

Banco Santander, S.A. ("Banco Santander" or the "Bank") informs that its Executive Committee has resolved to carry out an issue of contingent perpetual preferred securities convertible into newly issued ordinary shares of the Bank, excluding pre-emptive subscription rights and for a nominal value of up to EUR € 2,000,000,000 (the "Issue"). The Issue will be carried out through an accelerated bookbuilding process and will be targeted only at qualified investors.

Banco Santander will disclose the final terms of the Issue once they have been decided.

 

Boadilla del Monte (Madrid), 18 April 2017

 

 

 

 

 

 

 

IMPORTANT INFORMATION

This material fact does not constitute an offer to sell, or the solicitation of an offer to buy any securities, nor shall there be any sale of such securities in any state of the United States or in another jurisdiction in which such offer, solicitation or sale would not be permitted before registration or qualification under the securities laws of such state or jurisdiction. The securities described above have not been registered under the U.S. Securities Act of 1933, as amended, or any applicable securities laws of any other jurisdiction. Unless so registered, such securities may not be offered or sold in the United States or any other jurisdiction except pursuant to an exemption from the registration requirements of the U.S. Securities Act of 1933, as amended, and any applicable securities laws of such other jurisdiction.

This material fact does not constitute an offer document or an offer of transferable securities to the public in the United Kingdom to which section 85 of the Financial Services and Markets Act 2000 ("FSMA") applies and should not be considered as a recommendation that any person should subscribe for or purchase any of the securities described herein. These securities will not be offered or sold to any person in the United Kingdom except in circumstances which have not resulted and will not result in an offer to the public in the United Kingdom in contravention of section 85(1) of FSMA.

This material fact does not constitute an offer to the public in Italy of financial products, as defined under article 1, paragraph 1, letter (t) of legislative decree no. 58 of 24 February 1998, as amended (the "Financial Services Act"). The preferred securities cannot be offered or sold in the Republic of Italy either on the primary or on the secondary market to any natural persons nor to entities other than qualified investors (investitori qualificati) as defined pursuant to Article 100 of the Financial Services Act and Article 34-ter, paragraph 1, letter b) of Regulation No. 11971 of May 14, 1999, as amended (the "Issuers Regulations") issued by the Commissione Nazionale per le Società e la Borsa, the Italian securities and financial markets regulator ("CONSOB") or unless in circumstances which are exempt from the rules on public offers pursuant to Article 100 of the Financial Services Act and the implementing CONSOB regulations, including the Issuers Regulations. This material fact is for informational purposes only and does not constitute and shall not, in any circumstances, constitute a public offering or an invitation to the public in connection with any offer within the meaning of the Directive 2003/71/EC of the European Parliament and of the Council of 4 November 2003 on the prospectus to be published when securities are offered to the public or admitted to trading.

No action has been made or will be taken that would permit a public offering of any securities described herein in any jurisdiction in which action for that purpose is required. No offers, sales, resales or delivery of any securities described herein or distribution of any offering material relating to any such securities may be made in or from any jurisdiction except in circumstances which will result in compliance with any applicable laws and regulations and which will not impose any obligation on the Company or the Joint Lead Managers or any of their respective affiliates. Additionally, the preferred securities will not be offered, distributed or sold in Spain nor to Spanish residents.

This material fact is an announcement and not a prospectus and investors should not subscribe for or purchase any securities referred herein except on the basis of the information in the offering circular.

Restrictions on Marketing and Sales to Retail Investors

The Preferred Securities are not intended to be sold and should not be sold to retail clients in the European Economic Area, as defined in the rules set out in the Product Intervention (Contingent Convertible Instruments and Mutual Society Shares) Instrument 2015 (as amended or replaced from time to time) (the "PI Rules") other than in circumstances that do not and will not give rise to a contravention of those rules by any person. By making or accepting an offer to purchase any Preferred Securities from the Issuer or the Joint Lead Managers, each prospective investor will be deemed to have represented, warranted, and undertaken to the Issuer and each of the Joint Lead Managers that (i) it is not a retail client; and (ii) it will not take any action which would result in a breach by the Issuer or any other person of the PI Rules (as defined herein). Potential investors should read the whole of the related offering circular, in particular the "Risk Factors" section and the "Restrictions on Marketing and Sales to Retail Investors" section.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCQVLBFDZFZBBB
Date   Source Headline
3rd Aug 202112:13 pmRNSDirector/PDMR Shareholding
30th Jul 20215:13 pmRNSStress Test Results
30th Jul 202110:35 amRNSOptional early redemption ISIN XS1107291541
28th Jul 20217:00 amRNSFirst half 2021 results press release
28th Jul 20217:00 amRNS1H2021 results report & analyst presentation
27th Jul 20213:02 pmRNSNotice of First Half 2021 Results
15th Jul 20215:07 pmRNSAcquisition of Amherst Pierpont Presentation
15th Jul 20215:05 pmRNSSantander to acquire Amherst Pierpont
10th Jun 202112:11 pmRNSDirector/PDMR Shareholding
9th Jun 20217:00 amRNSSantander Mexico tender offer supplementary info
25th May 20217:00 amRNSSantander Mexico tender offer supplementary info
21st May 20218:43 amRNSForm 8.3 - RSA Insurance Group plc
7th May 20217:00 amRNSIssue of Preferred Tier 1 Securities CoCos
30th Apr 202112:03 pmRNSDirector/PDMR Shareholding
30th Apr 20218:04 amRNS2020 Banco Santander Annual Report
28th Apr 20217:00 amRNSFirst Quarter 2021 Earnings Presentation
28th Apr 20217:00 amRNSFirst Quarter 2021 Financial Report
28th Apr 20217:00 amRNSFirst Quarter 2021 press release
27th Apr 20213:06 pmRNSNotice of Results for the 1st Quarter 2021
20th Apr 202111:04 amRNSForm 8.3 - RSA Insurance Group
9th Apr 202112:53 pmRNSChange in the Group’s reportable segments
6th Apr 20211:51 pmRNSForm 8.3 - RSA Insurance Group Plc
26th Mar 20211:53 pmRNSAGM Resolutions
26th Mar 20217:00 amRNSInformation on Santander Mexico, dividends, Board
26th Mar 20217:00 amRNSSantander Mexico Tender Offer Presentation
26th Mar 20217:00 amRNSAnalysts call on Santander Mexico tender offer
26th Mar 20217:00 amRNSInformation on payment of dividends
19th Mar 202111:19 amRNSAdditional notice to the call to the AGM
11th Mar 20215:08 pmRNSDirector/PDMR Shareholding
11th Mar 20215:07 pmRNSDirector/PDMR Shareholding
26th Feb 202112:21 pmRNSDirector/PDMR Shareholding
26th Feb 202112:21 pmRNSDirector/PDMR Shareholding
23rd Feb 20214:13 pmRNSNotice of AGM
23rd Feb 20214:00 pmRNSAnnual Financial Report
18th Feb 20215:32 pmRNSDirector/PDMR Shareholding
18th Feb 20215:30 pmRNSDirector/PDMR Shareholding
18th Feb 20215:30 pmRNSDirector/PDMR Shareholding
18th Feb 20215:30 pmRNSDirector/PDMR Shareholding
18th Feb 20215:30 pmRNSDirector/PDMR Shareholding
18th Feb 20215:29 pmRNSDirector/PDMR Shareholding
18th Feb 20215:29 pmRNSDirector/PDMR Shareholding
18th Feb 20215:29 pmRNSDirector/PDMR Shareholding
18th Feb 20215:28 pmRNSDirector/PDMR Shareholding
18th Feb 20215:28 pmRNSDirector/PDMR Shareholding
18th Feb 20215:27 pmRNSDirector/PDMR Shareholding
18th Feb 20215:17 pmRNSDirector/PDMR Shareholding
18th Feb 20215:17 pmRNSDirector/PDMR Shareholding
18th Feb 20215:15 pmRNSDirector/PDMR Shareholding
18th Feb 20215:14 pmRNSDirector/PDMR Shareholding
18th Feb 20215:14 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.